Celldeg

Executive Summary

CellDEG GmbH is a German biotechnology company specializing in advanced photobioreactor systems for photoautotrophic cultivation. Founded in 2020 and based in Munich, the company has developed a patented High-Density Cultivation (HDC) technology that leverages membrane-mediated CO2 supply to achieve unprecedented biomass concentrations of up to 30 g dry weight per liter and productivities of 10 g/L/day. This breakthrough eliminates common limitations such as carbon depletion, oxygen stress, and water vapor loss, while maintaining high quantum yields even at photon flux densities exceeding 1000 µmol photons/m²/s. By enabling extreme biomass density and productivity, CellDEG's HDC photobioreactor platform offers a scalable and efficient solution for the production of microalgae and other photoautotrophic organisms, which are critical sources of bioactive compounds, recombinant proteins, and cell-based therapies. The implications for cell therapy and regenerative medicine are significant. Photoautotrophic systems can serve as low-cost, sustainable platforms for producing therapeutic proteins, growth factors, and even engineered cells. CellDEG's technology could reduce production costs and improve yields for these high-value products, accelerating the development of affordable therapies. While the company is still at an early stage (no disclosed funding or partnerships), its innovative approach addresses key bottlenecks in photosynthetic bioprocessing. If successfully scaled, CellDEG could become a key enabler in the biopharmaceutical supply chain, particularly for the growing field of algae-based therapeutics. The company’s focus on membrane bioreactor technology and extreme productivity sets it apart in the competitive landscape of photobioreactor manufacturers.